TLR9 and systemic lupus erythematosus: No CD107 up-regulation was observed in response to nucleosomes, whereas the TLR9 agonist induced a low and not significant (p = 0.078) CD107 up-regulation (Figure 7F), suggesting exhaustion of NK cells from SLE patients.